Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

SHBG may be a useful early indicator and treatment target for PCOS.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Some men with early hair loss may have a condition similar to PCOS in women.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

COVID-19 may harm male fertility and damage the reproductive system.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Deslorelin may help intact male dogs regrow hair from alopecia X, with a 75% success rate and no side effects.

Finasteride can cause muscle pain and high creatine kinase levels, but stopping the medication may resolve symptoms.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.